Department of Rheumatology, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru.
Lupus. 2019 Oct;28(11):1344-1349. doi: 10.1177/0961203319876998. Epub 2019 Sep 24.
The aim of this study was to determine whether remission and low disease activity state protect systemic lupus erythematosus patients from being hospitalized.
Patients from the Almenara Lupus Cohort were included. Visits were performed every 6 months. Variables were measured at each visit. Hospitalizations were evaluated in the interval between two visits. Remission was defined as: a SLEDAI-2 K of 0, prednisone ≤5 mg/day and immunosuppressants on maintenance dose; low disease activity state as: a SLEDAI-2 K of ≤4, prednisone ≤7.5 mg/day and immunosuppressants on maintenance dose. Univariable and multivariable interval-censored survival regression models were used. In multivariable analysis, possible confounders were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index (SDI) and Charlson comorbidity index. Confounders were determined in the same visit as disease activity state.
Of the 308 patients, 92.5% of them ( = 285) were women, had a mean age at diagnosis of 34.8 (13.4) years and a disease duration of 7.7 (6.5) years. At baseline the mean SDI was 1.13 (1.34). A total of 163 of the patients were hospitalized. In the multivariable analysis remission (hazard ratio 0.445 (0.274-0.725), = 0.001) and low disease activity state (relative risk 0.504 (0.336-0.757), = 0.001) at baseline were found to decrease the risk of hospitalization in systemic lupus erythematosus patients. A total of 158 hospitalizations presented a discernible cause. Disease activity was the most common cause of hospitalization, with 84 admissions (53.16%), the majority, 38, was due to active kidney disease (45.23%).
Remission and low disease activity state decreased the risk of hospitalizations in these systemic lupus erythematosus patients. Disease activity, particularly renal, was the most frequent cause of hospitalization.
本研究旨在确定缓解和低疾病活动状态是否能保护系统性红斑狼疮患者免于住院。
纳入了 Almenara 狼疮队列的患者。每 6 个月进行一次就诊。每次就诊时都会测量变量。在两次就诊之间评估住院情况。缓解定义为:SLEDAI-2K 得分为 0,泼尼松≤5mg/天,免疫抑制剂维持剂量;低疾病活动状态定义为:SLEDAI-2K 得分为≤4,泼尼松≤7.5mg/天,免疫抑制剂维持剂量。采用单变量和多变量间隔 censored 生存回归模型。在多变量分析中,可能的混杂因素包括性别、诊断时年龄、社会经济地位、教育水平、疾病持续时间、抗疟药物使用、系统性红斑狼疮国际合作诊所/美国风湿病学会损伤指数(SDI)和 Charlson 合并症指数。混杂因素是在与疾病活动状态相同的就诊时确定的。
在 308 名患者中,92.5%(285 名)为女性,平均诊断时年龄为 34.8(13.4)岁,疾病持续时间为 7.7(6.5)年。基线时平均 SDI 为 1.13(1.34)。共有 163 名患者住院。多变量分析发现,缓解(危险比 0.445(0.274-0.725), = 0.001)和低疾病活动状态(相对风险 0.504(0.336-0.757), = 0.001)基线时降低了系统性红斑狼疮患者住院的风险。共有 158 次住院有明确的病因。疾病活动是住院的最常见原因,共 84 例(53.16%),其中大多数,38 例,是由于活动性肾脏疾病(45.23%)。
缓解和低疾病活动状态降低了这些系统性红斑狼疮患者住院的风险。疾病活动,特别是肾脏疾病,是最常见的住院原因。